✦ LIBER ✦

Gene therapy shows promise for breast and ovarian cancer

✍ Scribed by Lisa Barrie Schwartz

Book ID: 117288403
Publisher: The Lancet
Year: 1998
Tongue: English
Weight: 130 KB
Volume: 351
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(05)60622-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dose-dense therapy shows promise in ovar

Dose-dense therapy shows promise in ovarian cancer

✍ Clare Sansom 📂 Article 📅 2004 🏛 The Lancet 🌐 English ⚖ 46 KB

Bevacizumab shows promise for high-risk

Bevacizumab shows promise for high-risk and recurrent ovarian cancer

✍ SUSAN LONDON 📂 Article 📅 2011 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 59 KB

Gene therapy shows promise against dry m

Gene therapy shows promise against dry mouth in cancer patients

✍ Mohindru, Pooja; Khanna, Rajesh; Bhatia, S. S. 📂 Article 📅 2012 🏛 Springer-Verlag ⚖ 75 KB

AZT shows promise as breast cancer fight

AZT shows promise as breast cancer fighter

✍ N. Seppa 📂 Article 📅 1997 🏛 Society for Science & the Public 🌐 English ⚖ 227 KB

Gene therapy for ovarian cancer

✍ Kristopher J. Kimball; T. Michael Numnum; Rodney P. Rocconi; Ronald D. Alvarez 📂 Article 📅 2006 🏛 Current Science Inc. 🌐 English ⚖ 229 KB

HMGA2 gene is a promising target for ova

HMGA2 gene is a promising target for ovarian cancer silencing therapy

✍ Anastasia Malek; Elena Bakhidze; Aurelia Noske; Christine Sers; Achim Aigner; Re 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 662 KB

## Abstract Ovarian cancer is one of the most lethal gynecological malignancies and the small success rate of routine therapeutic methods justifies efforts to develop new approaches. Evaluation of targets for effective inhibition of ovarian cancer cell growth should precipitate clinical application